Centene Corporation (CNC) Fair Value & Analysis
Healthcare · US · Market cap $32.9B
Centene Corporation
CNC · US
Fair value as of: Aug 13, 2026
From 9 valuation models · updated yesterday
Share price −3.9% over the past month.
A solid business, screening 70% undervalued on our models.
What matters now
- The price is below even our cautious bear case ($77.83). The market is more pessimistic than our downside scenario.
- Solid quality (62/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range ($77.83 to $146.08) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range $25.21 – $97.22 · fair‑value band $77.83 – $146.08 · the $66.04 price screens below the $111.96 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Centene Corporation (CNC) currently trades at $66.04, while our model-based Fair Value estimate is $111.96, implying the stock looks roughly 69.5% undervalued today. The Quality Score stands at 62/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Centene Corporation generated revenue of $178B at a net margin of -3.6%. Revenue grew 5.1% year over year. It earns a return on equity of -26.0%. Net debt stands at $889M. Fundamentals as of Aug 13, 2026
Our scenario range runs from $77.83 (bear case) to $146.08 (bull case); at $66.04, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 163% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -3% fair-value upside, at 70%, CNC screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 9 models by family
Widest divergence: DCF Models ($232.83) versus Dividend Discount ($2.87). Highest evidence: Growth DCF (80).
Notify me when CNC reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 60 · Market factors (momentum, volatility) 76
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other.
Full company description
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Centene Corporation reported revenue of $195B in FY2025 versus $126B in FY2021, a compound +11.5%/yr. Reported net income was −$6.7B in FY2025.
of which total revenue +23.3 pp · buybacks/dilution −9.4 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
Watch CNC: get an alert when its fair value changes →
Peer Group
Healthcare Plans · 15 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Healthcare Plans median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Healthcare Plans stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| UnitedHealth Group UNH | $405.59 | $292.06 | -28% |
| CVS Health Corporation CVS | $94.72 | $42.25 | -55% |
| Elevance Health, Inc ELV | $399.14 | $426.53 | +7% |
| The Cigna Group CI | $277.41 | $495.42 | +79% |
| Humana Inc HUM | $388.83 | $126.42 | -67% |
| Molina Healthcare, Inc MOH | $206.06 | $199.31 | -3% |
| Oscar Health, Inc OSCR | $29.61 | $59.22 | +100% |
| Alignment Healthcare, Inc ALHC | $13.52 | $2.37 | -82% |
| Progyny, Inc PGNY | $25.42 | $16.44 | -35% |
| Bradsaúde S.A SAUD3 | R$13.88 | R$17.73 | +28% |
Compare Centene Corporation with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Centene Corporation (CNC) overvalued or undervalued?
What is the fair value of CNC?
What is the quality score of CNC?
What is the revenue of Centene Corporation (CNC)?
What is the net profit margin of CNC?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Centene Corporation and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.